The Institute of Genetic Medicine at Newcastle University is equipped with the Genome Sequencer FLX System, Roche’s latest sequencing platform. Using technology established by 454 Life Sciences, the GS FLX system has the capacity to perform 400,000 sequencing reads in a single run. With potential sequencing reads of 200-300 bases, this creates a throughput approaching 100 million bases per run.
The GS FLX System offers a range of applications, including amplicon and gDNA resequencing, gene regulation and transcriptome studies, epigenetic (methylation) analysis, and de novo sequencing.
DNA sequencing using the GS FLX involves the application of revolutionary technology. The principal steps are listed below:
The Institute of Genetic Medicine has invested in the entire workflow required to prepare samples for GS FLX sequencing. We provide instruments for quantification of DNA (Agilent BioAnalyzer/PicoGreen Fluorometer), machinery for the preparation of emulsion PCR reactions (Qiagen TissueLyser), a particle counting facility (Beckman Coulter Counter), plus complete software packages for data analysis.
Enquiries regarding the use of the Roche GS FLX at the Institute of Genetic Medicine should be made to Dr Jonathan Coxhead, Facility Manager (j.m.coxhead@newcastle.ac.uk).